CAH

Cardinal Health Inc. Common Stock (CAH)

Stock · NYSE · Health Care

$234.55as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 29, 2026

Cardinal Health Sees Wave of Insider Stock Sales After Record High. Several senior executives and board members at Cardinal Health, including the CEO, CFO, and heads of the medical and pharmaceutical segments, have sold shares over the past week, according to recent filings. The largest transaction was the CEO selling roughly $29 million in stock over two days, following the company's earnings report that pushed shares to a record high. Other notable moves include the CFO selling about $9.9 million and the medical segment head selling around $8 million. While the chief accounting officer also reduced holdings, one insider reportedly grew her overall stake by 47% despite the sale, illustrating that insider transactions vary in context.

Price chart

Open in TradingView

Active signals

No technical signal is currently active for this symbol.

Support level
$209.75
Industry
Other Pharmaceuticals

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It…

Sector
Health Care
Industry
Other Pharmaceuticals
Employees
58,788

Fundamentals

1-day range
$229.33$235.26
Market cap
$55.18B
P/E (trailing)
32.57
P/E (forward)
16.77
EPS (trailing)
$7.22
Dividend yield
0.88%
Beta
0.52
Avg. volume
2.28M
Ex-dividend date
October 1, 2026
Dividend pay date
July 15, 2026
52-week range
$145.87$258.3
Next earnings: November 5, 2026 · EPS estimate $2.88confirmed

How Cardinal Health Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$222.58BNet Income$1.56B (1%)Cost of Revenue$214.41B (96%)SG&A$5.38B (2%)Other$693.00M (0%)Tax$532.00M (0%)CAH

Source: 10-K filed Aug 12, 2025 · via SEC EDGAR / Finnhub

Forecasts

15 analyst ratings

Buy 82%
Hold 18%
Sell 0%
1-year price forecast
High
$292
+24.5%
Median
$275
+17.2%
Low
$235
+0.2%

Cardinal Health Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CAH
    Cardinal Health Inc. Common Stock
    $234.55
    ▼ 0.25%
    Market cap $55.18BP/E 32.57
    $145.87$258.3
  • COR
    Cencora Inc. Common Stock
    $322.02
    ▲ 0.25%
    Market cap $60.00BP/E 22.54
    $244.82$377.54
  • MCK
    McKesson Corporation Common Stock
    $894.35
    ▲ 0.43%
    Market cap $99.43BP/E 21.89
    $677.28$999
  • HLF
    Herbalife Ltd. Common Shares
    $12.43
    ▲ 0.65%
    Market cap $1.32BP/E 7.68
    $7.56$20.4
  • NUS
    Nu Skin Enterprises Inc. Common Stock
    $4.85
    ▲ 2.54%
    Market cap $250.52MP/E 4.30
    $4.49$14.62
  • HKPD
    Cellyan Biotechnology Co. Ltd Class A Ordinary Shares
    $0.36
    ▼ 11.33%
    Market cap $16.93MP/E —
    $0.31$1.82
  • SCNX
    Scienture Holdings Inc. Common Stock
    $0.3938
    ▲ 3.63%
    Market cap $15.72MP/E —
    $0.2382$2.6

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
418.3K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
184.37M
Total value held
$36.79B
Institutional holders
1406
Top holders this quarter
  • Unknown28.49M
  • Unknown15.29M
  • Unknown12.07M
  • Unknown6.58M
  • Unknown4.95M
  • Unknown4.28M
  • Unknown4.24M
  • Unknown4.01M
  • Unknown3.51M
  • Unknown2.88M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.